Search

everythinglearnresearchcommunity

for

Search:↓

Some people still have COVID-19 symptoms after 90 days, especially older patients and those with severe initial symptoms, but most return to normal.

Autoimmune skin disorders are caused by genetic and environmental factors and are treated with various medications and preventative strategies.

Low testosterone can cause a heart rhythm problem in men, but fixing it can prevent the issue.

Hair loss in children is often caused by scalp infections, immune disorders, hair pulling, stress, and requires careful treatment due to emotional effects.

Hair microscopy is a simple and cost-effective method to help diagnose systemic diseases in children.

Poor nutrition can lead to skin diseases in hospitalized patients and should be quickly identified and treated.

People with hypohidrotic ectodermal dysplasia are more likely to experience long-term fatigue and hair loss after COVID-19.

Microneedles are promising for long-acting drug delivery and can improve patient compliance, but more data is needed to confirm their effectiveness.

Most hospitalized COVID-19 survivors in the study experienced long-term symptoms, affecting their daily life and mental functions.

Hair shedding after childbirth can reveal a pre-existing condition of hair loss due to tight hairstyles.

Proper hair care and suitable products are essential for men's scalp health and well-being.

Managing recurrent painless thyroiditis is challenging and should be personalized based on episode frequency, severity, symptoms, and patient preferences.

Ectoin helps prevent cortisone-induced skin problems and supports skin health.

Long COVID causes a wide range of long-lasting symptoms that change over time and are hard to diagnose and treat.

Weight loss can cause temporary hair loss, especially in women and older adults.

The conclusion is that treatments for Telogen Effluvium exist, but standard treatment guidelines are needed.

Ruxolitinib effectively and safely regrows hair in alopecia patients.

Type 1 diabetes often occurs with other autoimmune diseases, and personalized treatment based on genetics can improve outcomes.

Kidney transplant patients who had COVID-19 experienced a significant drop in their quality of life due to long-lasting symptoms.

Long COVID affects over half of COVID-19 survivors, causing a range of symptoms like fatigue and neurological issues, with no specific treatment yet.

One-third of COVID-19 patients had long-term symptoms like hair loss and fatigue, with women, older individuals, blood group B, smokers, and those with more virus exposure at higher risk.

New treatments for vitiligo show promise but still face challenges, especially for hands and feet.

COVID-19 can cause temporary hair loss, often starting around 7-8 weeks after recovery, with factors like Vitamin D deficiency, other diseases, medication, and stress potentially contributing.

Recognizing and managing central sensitization and stress is crucial for treating chronic pain.

ALRV5XR significantly improves hair density in women with hair loss and is well-tolerated.

Exosomes from fat-derived stem cells can potentially improve hair growth and could be a new treatment for immune-related hair loss.

Transgender patients in critical care need better-trained medical staff and specific guidelines.

Nanomaterials can improve hair care products and treatments, including hair loss and alopecia, by enhancing stability and safety, and allowing controlled release of compounds, but their safety in cosmetics needs more understanding.

Kampo medicine can help treat general fatigue from long COVID.

Injecting scalp tissue micrografts is a safe and effective treatment for hair loss after COVID-19.